Clinical Trial Update: Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden

View source ↗

Summary

Clinical trial update for an epidemiologic study evaluating IGRA positivity in populations with a high tuberculosis burden has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: Gates Medical Research Institute | Conditions: Tuberculosis, Pulmonary | Status: COMPLETED